Business Context and Reporting Period
This Form 8-K is a current report filed by Anthem, Inc. (now Elevance Health, Inc.) on March 13, 2018. The filing serves as a Regulation FD disclosure regarding upcoming investor communications scheduled between March 13, 2018, and March 30, 2018.
Key Financial Metrics
The filing does not provide historical revenue, profit, cash flow, or debt figures for the reporting period. It focuses exclusively on forward-looking earnings guidance for the full year 2018.
- Full Year 2018 Net Income Guidance: Greater than $14.28 per share.
- Net Negative Adjustment Items: Approximately $0.72 per share included in the net income guidance.
- Adjusted Net Income Guidance: Greater than $15.00 per share (excluding adjustment items).
Material Changes and Exclusions
The provided guidance explicitly excludes the financial impact of the following items:
- The acquisition of Freedom Health, Inc., Optimum HealthCare, Inc., America's 1st Choice of South Carolina, Inc., and related entities, completed on February 15, 2018.
- Investment gains or losses.
- Other-than-temporary impairment losses.
- Additional amortization of other intangible assets not included in the fourth quarter and full year 2017 outlook.
Guidance, Outlook, and Risks
Management intends to reaffirm the 2018 earnings guidance during the specified investor meetings. The filing includes an extensive list of risks and uncertainties that could cause actual results to differ materially from projections, including:
- Regulatory changes affecting the Affordable Care Act and Medicare/Medicaid programs.
- Trends in healthcare costs, utilization rates, and provider contracting.
- Competitive pressures and market share fluctuations.
- Litigation risks, specifically regarding the merger agreement with Cigna Corporation.
- Operational risks related to information systems, data privacy, and pharmacy benefit management agreements.
- Financial risks including indebtedness, credit rating downgrades, and potential impairment of intangible assets.
Investor Verification Checklist
- Verify the actual financial impact of the February 15, 2018, acquisition of Freedom Health and related entities, as this is excluded from current guidance.
- Monitor the status and potential financial outcome of the litigation between Anthem and Cigna Corporation.
- Review subsequent filings for updates on regulatory changes affecting Medicare and Medicaid funding and Star ratings.
- Confirm whether the company's ability to repurchase shares or pay dividends remains consistent with the stated cash flow and earnings adequacy.